Global Central Nervous System Disease Drugs Supply, Demand and Key Producers, 2023-2029
The global Central Nervous System Disease Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Central Nervous System Disease Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Central Nervous System Disease Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Central Nervous System Disease Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Central Nervous System Disease Drugs total market, 2018-2029, (USD Million)
Global Central Nervous System Disease Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Central Nervous System Disease Drugs total market, key domestic companies and share, (USD Million)
Global Central Nervous System Disease Drugs revenue by player and market share 2018-2023, (USD Million)
Global Central Nervous System Disease Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Central Nervous System Disease Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Central Nervous System Disease Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Central Nervous System Disease Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Central Nervous System Disease Drugs Market, By Region:
1. How big is the global Central Nervous System Disease Drugs market?
2. What is the demand of the global Central Nervous System Disease Drugs market?
3. What is the year over year growth of the global Central Nervous System Disease Drugs market?
4. What is the total value of the global Central Nervous System Disease Drugs market?
5. Who are the major players in the global Central Nervous System Disease Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Central Nervous System Disease Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Central Nervous System Disease Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Central Nervous System Disease Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Central Nervous System Disease Drugs total market, 2018-2029, (USD Million)
Global Central Nervous System Disease Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Central Nervous System Disease Drugs total market, key domestic companies and share, (USD Million)
Global Central Nervous System Disease Drugs revenue by player and market share 2018-2023, (USD Million)
Global Central Nervous System Disease Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Central Nervous System Disease Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Central Nervous System Disease Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Central Nervous System Disease Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Central Nervous System Disease Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antidepressants
- Antipsychotics
- Anti-Dementia Drugs
- Anti-Parkinson's Drugs
- Antiepileptic Drugs
- Others
- Hospital and Clinic
- Pharmacy
- Pfizer
- Biogen
- Otsuka
- Novartis
- Teva Pharmaceutical
- Johnson & Johnson
- AstraZeneca
- Merck
- GSK
- Eli Lilly and Company
- Lundbeck
- Takeda
- Bristol Myers Squibb
- Jiangsu Nhwa Pharmaceutical
- Luye Pharma
- Zhejiang Huahai Pharmaceutical
- Chengdu Easton Biopharmaceuticals
- Hansoh Pharmaceutical
1. How big is the global Central Nervous System Disease Drugs market?
2. What is the demand of the global Central Nervous System Disease Drugs market?
3. What is the year over year growth of the global Central Nervous System Disease Drugs market?
4. What is the total value of the global Central Nervous System Disease Drugs market?
5. Who are the major players in the global Central Nervous System Disease Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Central Nervous System Disease Drugs Introduction
1.2 World Central Nervous System Disease Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Central Nervous System Disease Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Central Nervous System Disease Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.3 China Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.4 Europe Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.5 Japan Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.6 South Korea Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.7 ASEAN Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.8 India Central Nervous System Disease Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Central Nervous System Disease Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Central Nervous System Disease Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.2 World Central Nervous System Disease Drugs Consumption Value by Region
2.2.1 World Central Nervous System Disease Drugs Consumption Value by Region (2018-2023)
2.2.2 World Central Nervous System Disease Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.4 China Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.5 Europe Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.6 Japan Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.7 South Korea Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.8 ASEAN Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.9 India Central Nervous System Disease Drugs Consumption Value (2018-2029)
3 WORLD CENTRAL NERVOUS SYSTEM DISEASE DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Central Nervous System Disease Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Central Nervous System Disease Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Central Nervous System Disease Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Central Nervous System Disease Drugs in 2022
3.3 Central Nervous System Disease Drugs Company Evaluation Quadrant
3.4 Central Nervous System Disease Drugs Market: Overall Company Footprint Analysis
3.4.1 Central Nervous System Disease Drugs Market: Region Footprint
3.4.2 Central Nervous System Disease Drugs Market: Company Product Type Footprint
3.4.3 Central Nervous System Disease Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Central Nervous System Disease Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Central Nervous System Disease Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Central Nervous System Disease Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Central Nervous System Disease Drugs Consumption Value Comparison
4.2.1 United States VS China: Central Nervous System Disease Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Central Nervous System Disease Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Central Nervous System Disease Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
4.4 China Based Companies Central Nervous System Disease Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Central Nervous System Disease Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
4.5 Rest of World Based Central Nervous System Disease Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Central Nervous System Disease Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antidepressants
5.2.2 Antipsychotics
5.2.3 Anti-Dementia Drugs
5.2.4 Anti-Parkinson's Drugs
5.2.5 Antiepileptic Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Central Nervous System Disease Drugs Market Size by Type (2018-2023)
5.3.2 World Central Nervous System Disease Drugs Market Size by Type (2024-2029)
5.3.3 World Central Nervous System Disease Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Central Nervous System Disease Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital and Clinic
6.2.2 Pharmacy
6.3 Market Segment by Application
6.3.1 World Central Nervous System Disease Drugs Market Size by Application (2018-2023)
6.3.2 World Central Nervous System Disease Drugs Market Size by Application (2024-2029)
6.3.3 World Central Nervous System Disease Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Central Nervous System Disease Drugs Product and Services
7.1.4 Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Central Nervous System Disease Drugs Product and Services
7.2.4 Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Otsuka
7.3.1 Otsuka Details
7.3.2 Otsuka Major Business
7.3.3 Otsuka Central Nervous System Disease Drugs Product and Services
7.3.4 Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Otsuka Recent Developments/Updates
7.3.6 Otsuka Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Central Nervous System Disease Drugs Product and Services
7.4.4 Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Details
7.5.2 Teva Pharmaceutical Major Business
7.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.5.4 Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Pharmaceutical Recent Developments/Updates
7.5.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Central Nervous System Disease Drugs Product and Services
7.6.4 Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Central Nervous System Disease Drugs Product and Services
7.7.4 AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck Central Nervous System Disease Drugs Product and Services
7.8.4 Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK Central Nervous System Disease Drugs Product and Services
7.9.4 GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Product and Services
7.10.4 Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.11 Lundbeck
7.11.1 Lundbeck Details
7.11.2 Lundbeck Major Business
7.11.3 Lundbeck Central Nervous System Disease Drugs Product and Services
7.11.4 Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Lundbeck Recent Developments/Updates
7.11.6 Lundbeck Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Central Nervous System Disease Drugs Product and Services
7.12.4 Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 Bristol Myers Squibb
7.13.1 Bristol Myers Squibb Details
7.13.2 Bristol Myers Squibb Major Business
7.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Product and Services
7.13.4 Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Bristol Myers Squibb Recent Developments/Updates
7.13.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.14 Jiangsu Nhwa Pharmaceutical
7.14.1 Jiangsu Nhwa Pharmaceutical Details
7.14.2 Jiangsu Nhwa Pharmaceutical Major Business
7.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.14.4 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
7.14.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
7.15 Luye Pharma
7.15.1 Luye Pharma Details
7.15.2 Luye Pharma Major Business
7.15.3 Luye Pharma Central Nervous System Disease Drugs Product and Services
7.15.4 Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Luye Pharma Recent Developments/Updates
7.15.6 Luye Pharma Competitive Strengths & Weaknesses
7.16 Zhejiang Huahai Pharmaceutical
7.16.1 Zhejiang Huahai Pharmaceutical Details
7.16.2 Zhejiang Huahai Pharmaceutical Major Business
7.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.16.4 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.16.6 Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
7.17 Chengdu Easton Biopharmaceuticals
7.17.1 Chengdu Easton Biopharmaceuticals Details
7.17.2 Chengdu Easton Biopharmaceuticals Major Business
7.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product and Services
7.17.4 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
7.17.6 Chengdu Easton Biopharmaceuticals Competitive Strengths & Weaknesses
7.18 Hansoh Pharmaceutical
7.18.1 Hansoh Pharmaceutical Details
7.18.2 Hansoh Pharmaceutical Major Business
7.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.18.4 Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Hansoh Pharmaceutical Recent Developments/Updates
7.18.6 Hansoh Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Central Nervous System Disease Drugs Industry Chain
8.2 Central Nervous System Disease Drugs Upstream Analysis
8.3 Central Nervous System Disease Drugs Midstream Analysis
8.4 Central Nervous System Disease Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Central Nervous System Disease Drugs Introduction
1.2 World Central Nervous System Disease Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Central Nervous System Disease Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Central Nervous System Disease Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.3 China Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.4 Europe Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.5 Japan Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.6 South Korea Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.7 ASEAN Central Nervous System Disease Drugs Market Size (2018-2029)
1.3.8 India Central Nervous System Disease Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Central Nervous System Disease Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Central Nervous System Disease Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.2 World Central Nervous System Disease Drugs Consumption Value by Region
2.2.1 World Central Nervous System Disease Drugs Consumption Value by Region (2018-2023)
2.2.2 World Central Nervous System Disease Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.4 China Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.5 Europe Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.6 Japan Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.7 South Korea Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.8 ASEAN Central Nervous System Disease Drugs Consumption Value (2018-2029)
2.9 India Central Nervous System Disease Drugs Consumption Value (2018-2029)
3 WORLD CENTRAL NERVOUS SYSTEM DISEASE DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Central Nervous System Disease Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Central Nervous System Disease Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Central Nervous System Disease Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Central Nervous System Disease Drugs in 2022
3.3 Central Nervous System Disease Drugs Company Evaluation Quadrant
3.4 Central Nervous System Disease Drugs Market: Overall Company Footprint Analysis
3.4.1 Central Nervous System Disease Drugs Market: Region Footprint
3.4.2 Central Nervous System Disease Drugs Market: Company Product Type Footprint
3.4.3 Central Nervous System Disease Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Central Nervous System Disease Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Central Nervous System Disease Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Central Nervous System Disease Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Central Nervous System Disease Drugs Consumption Value Comparison
4.2.1 United States VS China: Central Nervous System Disease Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Central Nervous System Disease Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Central Nervous System Disease Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
4.4 China Based Companies Central Nervous System Disease Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Central Nervous System Disease Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
4.5 Rest of World Based Central Nervous System Disease Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Central Nervous System Disease Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antidepressants
5.2.2 Antipsychotics
5.2.3 Anti-Dementia Drugs
5.2.4 Anti-Parkinson's Drugs
5.2.5 Antiepileptic Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Central Nervous System Disease Drugs Market Size by Type (2018-2023)
5.3.2 World Central Nervous System Disease Drugs Market Size by Type (2024-2029)
5.3.3 World Central Nervous System Disease Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Central Nervous System Disease Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital and Clinic
6.2.2 Pharmacy
6.3 Market Segment by Application
6.3.1 World Central Nervous System Disease Drugs Market Size by Application (2018-2023)
6.3.2 World Central Nervous System Disease Drugs Market Size by Application (2024-2029)
6.3.3 World Central Nervous System Disease Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Central Nervous System Disease Drugs Product and Services
7.1.4 Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Central Nervous System Disease Drugs Product and Services
7.2.4 Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Otsuka
7.3.1 Otsuka Details
7.3.2 Otsuka Major Business
7.3.3 Otsuka Central Nervous System Disease Drugs Product and Services
7.3.4 Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Otsuka Recent Developments/Updates
7.3.6 Otsuka Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Central Nervous System Disease Drugs Product and Services
7.4.4 Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Details
7.5.2 Teva Pharmaceutical Major Business
7.5.3 Teva Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.5.4 Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Pharmaceutical Recent Developments/Updates
7.5.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Central Nervous System Disease Drugs Product and Services
7.6.4 Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Central Nervous System Disease Drugs Product and Services
7.7.4 AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck Central Nervous System Disease Drugs Product and Services
7.8.4 Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK Central Nervous System Disease Drugs Product and Services
7.9.4 GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Central Nervous System Disease Drugs Product and Services
7.10.4 Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.11 Lundbeck
7.11.1 Lundbeck Details
7.11.2 Lundbeck Major Business
7.11.3 Lundbeck Central Nervous System Disease Drugs Product and Services
7.11.4 Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Lundbeck Recent Developments/Updates
7.11.6 Lundbeck Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Central Nervous System Disease Drugs Product and Services
7.12.4 Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 Bristol Myers Squibb
7.13.1 Bristol Myers Squibb Details
7.13.2 Bristol Myers Squibb Major Business
7.13.3 Bristol Myers Squibb Central Nervous System Disease Drugs Product and Services
7.13.4 Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Bristol Myers Squibb Recent Developments/Updates
7.13.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.14 Jiangsu Nhwa Pharmaceutical
7.14.1 Jiangsu Nhwa Pharmaceutical Details
7.14.2 Jiangsu Nhwa Pharmaceutical Major Business
7.14.3 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.14.4 Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
7.14.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
7.15 Luye Pharma
7.15.1 Luye Pharma Details
7.15.2 Luye Pharma Major Business
7.15.3 Luye Pharma Central Nervous System Disease Drugs Product and Services
7.15.4 Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Luye Pharma Recent Developments/Updates
7.15.6 Luye Pharma Competitive Strengths & Weaknesses
7.16 Zhejiang Huahai Pharmaceutical
7.16.1 Zhejiang Huahai Pharmaceutical Details
7.16.2 Zhejiang Huahai Pharmaceutical Major Business
7.16.3 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.16.4 Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.16.6 Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
7.17 Chengdu Easton Biopharmaceuticals
7.17.1 Chengdu Easton Biopharmaceuticals Details
7.17.2 Chengdu Easton Biopharmaceuticals Major Business
7.17.3 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product and Services
7.17.4 Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
7.17.6 Chengdu Easton Biopharmaceuticals Competitive Strengths & Weaknesses
7.18 Hansoh Pharmaceutical
7.18.1 Hansoh Pharmaceutical Details
7.18.2 Hansoh Pharmaceutical Major Business
7.18.3 Hansoh Pharmaceutical Central Nervous System Disease Drugs Product and Services
7.18.4 Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Hansoh Pharmaceutical Recent Developments/Updates
7.18.6 Hansoh Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Central Nervous System Disease Drugs Industry Chain
8.2 Central Nervous System Disease Drugs Upstream Analysis
8.3 Central Nervous System Disease Drugs Midstream Analysis
8.4 Central Nervous System Disease Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Central Nervous System Disease Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Central Nervous System Disease Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Central Nervous System Disease Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Central Nervous System Disease Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Central Nervous System Disease Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Central Nervous System Disease Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Central Nervous System Disease Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Central Nervous System Disease Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Central Nervous System Disease Drugs Players in 2022
Table 12. World Central Nervous System Disease Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Central Nervous System Disease Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Central Nervous System Disease Drugs Player
Table 15. Central Nervous System Disease Drugs Market: Company Product Type Footprint
Table 16. Central Nervous System Disease Drugs Market: Company Product Application Footprint
Table 17. Central Nervous System Disease Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Central Nervous System Disease Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Central Nervous System Disease Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 23. China Based Central Nervous System Disease Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 29. World Central Nervous System Disease Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Central Nervous System Disease Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Central Nervous System Disease Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Central Nervous System Disease Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Basic Information, Area Served and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Central Nervous System Disease Drugs Product and Services
Table 38. Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Recent Developments/Updates
Table 40. Pfizer Competitive Strengths & Weaknesses
Table 41. Biogen Basic Information, Area Served and Competitors
Table 42. Biogen Major Business
Table 43. Biogen Central Nervous System Disease Drugs Product and Services
Table 44. Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Biogen Recent Developments/Updates
Table 46. Biogen Competitive Strengths & Weaknesses
Table 47. Otsuka Basic Information, Area Served and Competitors
Table 48. Otsuka Major Business
Table 49. Otsuka Central Nervous System Disease Drugs Product and Services
Table 50. Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Otsuka Recent Developments/Updates
Table 52. Otsuka Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Area Served and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Central Nervous System Disease Drugs Product and Services
Table 56. Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceutical Major Business
Table 61. Teva Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 62. Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Teva Pharmaceutical Recent Developments/Updates
Table 64. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Johnson & Johnson Basic Information, Area Served and Competitors
Table 66. Johnson & Johnson Major Business
Table 67. Johnson & Johnson Central Nervous System Disease Drugs Product and Services
Table 68. Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Johnson & Johnson Recent Developments/Updates
Table 70. Johnson & Johnson Competitive Strengths & Weaknesses
Table 71. AstraZeneca Basic Information, Area Served and Competitors
Table 72. AstraZeneca Major Business
Table 73. AstraZeneca Central Nervous System Disease Drugs Product and Services
Table 74. AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AstraZeneca Recent Developments/Updates
Table 76. AstraZeneca Competitive Strengths & Weaknesses
Table 77. Merck Basic Information, Area Served and Competitors
Table 78. Merck Major Business
Table 79. Merck Central Nervous System Disease Drugs Product and Services
Table 80. Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck Recent Developments/Updates
Table 82. Merck Competitive Strengths & Weaknesses
Table 83. GSK Basic Information, Area Served and Competitors
Table 84. GSK Major Business
Table 85. GSK Central Nervous System Disease Drugs Product and Services
Table 86. GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GSK Recent Developments/Updates
Table 88. GSK Competitive Strengths & Weaknesses
Table 89. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 90. Eli Lilly and Company Major Business
Table 91. Eli Lilly and Company Central Nervous System Disease Drugs Product and Services
Table 92. Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Eli Lilly and Company Recent Developments/Updates
Table 94. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 95. Lundbeck Basic Information, Area Served and Competitors
Table 96. Lundbeck Major Business
Table 97. Lundbeck Central Nervous System Disease Drugs Product and Services
Table 98. Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Lundbeck Recent Developments/Updates
Table 100. Lundbeck Competitive Strengths & Weaknesses
Table 101. Takeda Basic Information, Area Served and Competitors
Table 102. Takeda Major Business
Table 103. Takeda Central Nervous System Disease Drugs Product and Services
Table 104. Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Takeda Recent Developments/Updates
Table 106. Takeda Competitive Strengths & Weaknesses
Table 107. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 108. Bristol Myers Squibb Major Business
Table 109. Bristol Myers Squibb Central Nervous System Disease Drugs Product and Services
Table 110. Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Bristol Myers Squibb Recent Developments/Updates
Table 112. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 113. Jiangsu Nhwa Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Jiangsu Nhwa Pharmaceutical Major Business
Table 115. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 116. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 118. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Luye Pharma Basic Information, Area Served and Competitors
Table 120. Luye Pharma Major Business
Table 121. Luye Pharma Central Nervous System Disease Drugs Product and Services
Table 122. Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Luye Pharma Recent Developments/Updates
Table 124. Luye Pharma Competitive Strengths & Weaknesses
Table 125. Zhejiang Huahai Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Zhejiang Huahai Pharmaceutical Major Business
Table 127. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 128. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 130. Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Chengdu Easton Biopharmaceuticals Basic Information, Area Served and Competitors
Table 132. Chengdu Easton Biopharmaceuticals Major Business
Table 133. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product and Services
Table 134. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 136. Hansoh Pharmaceutical Basic Information, Area Served and Competitors
Table 137. Hansoh Pharmaceutical Major Business
Table 138. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 139. Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Central Nervous System Disease Drugs Upstream (Raw Materials)
Table 141. Central Nervous System Disease Drugs Typical Customers
Table 1. World Central Nervous System Disease Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Central Nervous System Disease Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Central Nervous System Disease Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Central Nervous System Disease Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Central Nervous System Disease Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Central Nervous System Disease Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Central Nervous System Disease Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Central Nervous System Disease Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Central Nervous System Disease Drugs Players in 2022
Table 12. World Central Nervous System Disease Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Central Nervous System Disease Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Central Nervous System Disease Drugs Player
Table 15. Central Nervous System Disease Drugs Market: Company Product Type Footprint
Table 16. Central Nervous System Disease Drugs Market: Company Product Application Footprint
Table 17. Central Nervous System Disease Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Central Nervous System Disease Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Central Nervous System Disease Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 23. China Based Central Nervous System Disease Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Central Nervous System Disease Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Central Nervous System Disease Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Central Nervous System Disease Drugs Revenue Market Share (2018-2023)
Table 29. World Central Nervous System Disease Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Central Nervous System Disease Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Central Nervous System Disease Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Central Nervous System Disease Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Central Nervous System Disease Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Central Nervous System Disease Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Basic Information, Area Served and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Central Nervous System Disease Drugs Product and Services
Table 38. Pfizer Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Recent Developments/Updates
Table 40. Pfizer Competitive Strengths & Weaknesses
Table 41. Biogen Basic Information, Area Served and Competitors
Table 42. Biogen Major Business
Table 43. Biogen Central Nervous System Disease Drugs Product and Services
Table 44. Biogen Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Biogen Recent Developments/Updates
Table 46. Biogen Competitive Strengths & Weaknesses
Table 47. Otsuka Basic Information, Area Served and Competitors
Table 48. Otsuka Major Business
Table 49. Otsuka Central Nervous System Disease Drugs Product and Services
Table 50. Otsuka Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Otsuka Recent Developments/Updates
Table 52. Otsuka Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Area Served and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Central Nervous System Disease Drugs Product and Services
Table 56. Novartis Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceutical Major Business
Table 61. Teva Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 62. Teva Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Teva Pharmaceutical Recent Developments/Updates
Table 64. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Johnson & Johnson Basic Information, Area Served and Competitors
Table 66. Johnson & Johnson Major Business
Table 67. Johnson & Johnson Central Nervous System Disease Drugs Product and Services
Table 68. Johnson & Johnson Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Johnson & Johnson Recent Developments/Updates
Table 70. Johnson & Johnson Competitive Strengths & Weaknesses
Table 71. AstraZeneca Basic Information, Area Served and Competitors
Table 72. AstraZeneca Major Business
Table 73. AstraZeneca Central Nervous System Disease Drugs Product and Services
Table 74. AstraZeneca Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AstraZeneca Recent Developments/Updates
Table 76. AstraZeneca Competitive Strengths & Weaknesses
Table 77. Merck Basic Information, Area Served and Competitors
Table 78. Merck Major Business
Table 79. Merck Central Nervous System Disease Drugs Product and Services
Table 80. Merck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck Recent Developments/Updates
Table 82. Merck Competitive Strengths & Weaknesses
Table 83. GSK Basic Information, Area Served and Competitors
Table 84. GSK Major Business
Table 85. GSK Central Nervous System Disease Drugs Product and Services
Table 86. GSK Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GSK Recent Developments/Updates
Table 88. GSK Competitive Strengths & Weaknesses
Table 89. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 90. Eli Lilly and Company Major Business
Table 91. Eli Lilly and Company Central Nervous System Disease Drugs Product and Services
Table 92. Eli Lilly and Company Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Eli Lilly and Company Recent Developments/Updates
Table 94. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 95. Lundbeck Basic Information, Area Served and Competitors
Table 96. Lundbeck Major Business
Table 97. Lundbeck Central Nervous System Disease Drugs Product and Services
Table 98. Lundbeck Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Lundbeck Recent Developments/Updates
Table 100. Lundbeck Competitive Strengths & Weaknesses
Table 101. Takeda Basic Information, Area Served and Competitors
Table 102. Takeda Major Business
Table 103. Takeda Central Nervous System Disease Drugs Product and Services
Table 104. Takeda Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Takeda Recent Developments/Updates
Table 106. Takeda Competitive Strengths & Weaknesses
Table 107. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 108. Bristol Myers Squibb Major Business
Table 109. Bristol Myers Squibb Central Nervous System Disease Drugs Product and Services
Table 110. Bristol Myers Squibb Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Bristol Myers Squibb Recent Developments/Updates
Table 112. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 113. Jiangsu Nhwa Pharmaceutical Basic Information, Area Served and Competitors
Table 114. Jiangsu Nhwa Pharmaceutical Major Business
Table 115. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 116. Jiangsu Nhwa Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 118. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 119. Luye Pharma Basic Information, Area Served and Competitors
Table 120. Luye Pharma Major Business
Table 121. Luye Pharma Central Nervous System Disease Drugs Product and Services
Table 122. Luye Pharma Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Luye Pharma Recent Developments/Updates
Table 124. Luye Pharma Competitive Strengths & Weaknesses
Table 125. Zhejiang Huahai Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Zhejiang Huahai Pharmaceutical Major Business
Table 127. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 128. Zhejiang Huahai Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 130. Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Chengdu Easton Biopharmaceuticals Basic Information, Area Served and Competitors
Table 132. Chengdu Easton Biopharmaceuticals Major Business
Table 133. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Product and Services
Table 134. Chengdu Easton Biopharmaceuticals Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 136. Hansoh Pharmaceutical Basic Information, Area Served and Competitors
Table 137. Hansoh Pharmaceutical Major Business
Table 138. Hansoh Pharmaceutical Central Nervous System Disease Drugs Product and Services
Table 139. Hansoh Pharmaceutical Central Nervous System Disease Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Central Nervous System Disease Drugs Upstream (Raw Materials)
Table 141. Central Nervous System Disease Drugs Typical Customers
LIST OF FIGURES
Figure 1. Central Nervous System Disease Drugs Picture
Figure 2. World Central Nervous System Disease Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Central Nervous System Disease Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Central Nervous System Disease Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Central Nervous System Disease Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Central Nervous System Disease Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Central Nervous System Disease Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Central Nervous System Disease Drugs Markets in 2022
Figure 27. United States VS China: Central Nervous System Disease Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Central Nervous System Disease Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Central Nervous System Disease Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Central Nervous System Disease Drugs Market Size Market Share by Type in 2022
Figure 31. Antidepressants
Figure 32. Antipsychotics
Figure 33. Anti-Dementia Drugs
Figure 34. Anti-Parkinson's Drugs
Figure 35. Antiepileptic Drugs
Figure 36. Others
Figure 37. World Central Nervous System Disease Drugs Market Size Market Share by Type (2018-2029)
Figure 38. World Central Nervous System Disease Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Central Nervous System Disease Drugs Market Size Market Share by Application in 2022
Figure 40. Hospital and Clinic
Figure 41. Pharmacy
Figure 42. Central Nervous System Disease Drugs Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Central Nervous System Disease Drugs Picture
Figure 2. World Central Nervous System Disease Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Central Nervous System Disease Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Central Nervous System Disease Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Central Nervous System Disease Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Central Nervous System Disease Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Central Nervous System Disease Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Central Nervous System Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Central Nervous System Disease Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Central Nervous System Disease Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Central Nervous System Disease Drugs Markets in 2022
Figure 27. United States VS China: Central Nervous System Disease Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Central Nervous System Disease Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Central Nervous System Disease Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Central Nervous System Disease Drugs Market Size Market Share by Type in 2022
Figure 31. Antidepressants
Figure 32. Antipsychotics
Figure 33. Anti-Dementia Drugs
Figure 34. Anti-Parkinson's Drugs
Figure 35. Antiepileptic Drugs
Figure 36. Others
Figure 37. World Central Nervous System Disease Drugs Market Size Market Share by Type (2018-2029)
Figure 38. World Central Nervous System Disease Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Central Nervous System Disease Drugs Market Size Market Share by Application in 2022
Figure 40. Hospital and Clinic
Figure 41. Pharmacy
Figure 42. Central Nervous System Disease Drugs Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
